Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-17-027140
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-07 16:55:23
Reporting Period:
2017-09-06
Accepted Time:
2017-09-07 16:55:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1665678 Charles Alpuche C/o Insulet Corporation
600 Technology Park Drive, Suite 200
Billerica MA 01821
Evp, Global Manufacturing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-06 2,500 $58.08 34,709 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $57.97 to $58.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. Includes 10,681 restricted stock units granted on February 3, 2016, which vest one-half of the total units on February 3, 2018 and one-half of the total units on February 3, 2019; and 10,818 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  3. Includes an aggregate of 613 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on May 31, 2017.